Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
José M. González‐Navajas, Dengxia Denise Fan, Shuang Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Christopher Tay, Atsushi Tanaka, Shimon Sakaguchi
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 450-465
Open Access | Times Cited: 207
Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
Natalija Budimir, Graham D. Thomas, Joseph S. Dolina, et al.
Cancer Immunology Research (2021) Vol. 10, Iss. 2, pp. 146-153
Open Access | Times Cited: 165
Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine
Shogo Kumagai, Kota Itahashi, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 337-353
Closed Access | Times Cited: 28
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
Jong‐Dae Lee, Beatriz Lozano‐Ruiz, Fengyuan Mandy Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 70
Regulation of regulatory T cells and tumor‐associated macrophages in gastric cancer tumor microenvironment
Shaopeng Zhang, Yang Zheng, Fang Yuan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 6
Clinical benefit of immune checkpoint inhibitors in elderly cancer patients: Current evidence from immunosenescence pathophysiology to clinical trial results
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Katerina Aravantinou, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104635-104635
Open Access
The Mechanisms and Therapeutic Implications of Metabolic Communication in the Tumor-Immune Microenvironment
Mahmoud Singer, Rania Hamdy, Tasneem M. Elsayed, et al.
(2025), pp. 291-315
Closed Access
Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage
Fanqin Wei, Ruihua Fang, Kexing Lyu, et al.
Oral Oncology (2023) Vol. 145, pp. 106532-106532
Closed Access | Times Cited: 18
Progresses in biomarkers for cancer immunotherapy
Xuwen Lin, Chenyu Zong, Zhihan Zhang, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 15
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Heterogeneous pseudobulk simulation enables realistic benchmarking of cell-type deconvolution methods
Mengying Hu, Maria Chikina
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity
Ying Wang, Carolin Ertl, Christina Schmitt, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON)
Joshua Tobias, Marina Maglakelidze, Zoran Andrić, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 4044-4054
Open Access | Times Cited: 3
The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis
Wanli Yang, Wei Zhou, Xinhui Zhao, et al.
Hereditas (2021) Vol. 158, Iss. 1
Open Access | Times Cited: 23
Leveraging biomaterials for enhancing T cell immunotherapy
Ziyan Liao, Wentao Zhang, Hanqi Zheng, et al.
Journal of Controlled Release (2022) Vol. 344, pp. 272-288
Closed Access | Times Cited: 17
Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies
Daniel Rönen, Aseel Bsoul, Michal Lotem, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 540-540
Open Access | Times Cited: 17
InstaPrism: an R package for fast implementation of BayesPrism
Mengying Hu, Maria Chikina
Bioinformatics (2024) Vol. 40, Iss. 7
Open Access | Times Cited: 2
Regulatory T Cells in Pancreatic Cancer: Of Mice and Men
Carmen Mota Reyes, Elke Demir, Kaan Çifcibaşı, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4582-4582
Open Access | Times Cited: 13
Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment
Jingfang Lv, Zheng Jiang, Junhu Yuan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer
Peter Grell, Simona Bořilová, Pavel Fabián, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1901-1901
Open Access | Times Cited: 7
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Ivana Spasevska, Ankush Sharma, Chloé B. Steen, et al.
Blood Advances (2023) Vol. 7, Iss. 23, pp. 7216-7230
Open Access | Times Cited: 7
Heterogeneous pseudobulk simulation enables realistic benchmarking of cell-type deconvolution methods
Mengying Hu, Maria Chikina
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
InstaPrism: an R package for fast implementation of BayesPrism
Mengying Hu, Maria Chikina
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top